Thuja Capital
Finance · Netherlands · 1-10 Employees
View Company Info for Free
Overview
Headquarters
Yalelaan 62, Utrecht, Utrecht, 3521, Net...Phone Number
+31 619258566Website
www.thujacapital.comRevenue
<$5 MillionIndustry
About Thuja Capital
Thuja Capital Org Chart
Is Thuja Capital your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Thuja Capital recently announced quarterly report
Check if Thuja Capital has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Thuja Capital launches new products
Click to see if Thuja Capital had a recent Job posting/layoffs
Check out if Thuja Capital is spiking on competitors!
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Thuja Capital has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Thuja Capital
Thuja Capital, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined Thuja Capital as Masked Content
Find 3 more new buyers
Company Profile Activity
Activity Insights
Thuja Capital is experiencing very low activity levels compared to other companies in the Finance sector.
What does this means?
Thuja Capital is drawing exceptional interest within the Finance industry, suggesting notable developments or strong market momentum, learn more about Thuja Capital.
Thuja Capital Tech Stack
A closer look at the technologies used by Thuja Capital
Most Recent Scoops
Thuja Capital News & Media
Gradient Denervation Technologies closes €14m Series A led by Sabadell Asabys
PARIS--(BUSINESS WIRE)--Gradient Denervation Technologies closes €14m Series A led by Sabadell Asabys. Thuja Capital and founding investor Sofinnova Partners joined the roundSynerkine Pharma Raises EUR3.3 Million in Series A Financing
UTRECHT, Netherlands--(BUSINESS WIRE)--Synerkine Pharma Raises EUR3.3 Million Series A to advance novel fusion proteins for the treatment of inflammatory, neuropathic & osteoarthritic pain
Top Finance Companies
Frequently Asked Questions Regarding Thuja Capital
Thuja Capital is a leading early-stage venture capital firm focused on investing in innovative life science companies across Europe. The firm partners with visionary CEOs to create a transformative impact on healthcare by leveraging deep sector expertise and a strong network in academia, industry, and clinical research. Their goal is to empower bre... Read More